Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Neurology

Journal Scan / Research · January 26, 2024

Pimavanserin for Psychosis in Patients With Parkinson's Disease Dementia

Parkinsonism & Related Disorders


Additional Info

Parkinsonism & Related Disorders
Pimavanserin for psychosis in Parkinson's disease dementia: Subgroup analysis of the HARMONY Trial
Parkinsonism Relat. Disord. 2023 Dec 12;119(xx)105951, D Weintraub, AJ Espay, VD Sharma, PN Tariot, V Abler, S Pathak, S Stankovic

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading